Katherine Stueland

Katherine Stueland

Chief Executive OfficeratGeneDx Holdings· In proxies 2022–2025

Pay in FY2025+206% from the year before · GeneDx Holdings stock +69.2% the same year

Katherine Stueland was paid $13.5M in FY2025 (Dec), up 206%. GeneDx Holdings stock rose 69.2% that year.

Pay$100 in the stock at the end of FY21 → $88
Pay is from the Summary Compensation Table of each GeneDx Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeneDx HoldingsPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -56%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?